Outsourced Pharma Capabilities Update May 2026: Mammalian Cell Culture

This online event brings together pharmaceutical and biotechnology companies with contract development and manufacturing organizations (CDMOs) specializing in mammalian cell culture–based biologics production. Through a series of concise presentations, participating CDMOs showcase their capabilities across the biologics development lifecycle, including cell line development, upstream and downstream process development, scale-up, and GMP manufacturing.

The event is designed to help drug developers evaluate potential outsourcing partners by highlighting available capacity, technical platforms, facility infrastructure, and expertise in producing complex biologics such as monoclonal antibodies and recombinant proteins. Attendees gain practical insights into manufacturing strategies, timelines, and partnership models while having the opportunity to engage directly with CDMO experts to determine the best fit for their development and commercialization needs.